Labcorp Shares Outstanding 2010-2024 | LH

Labcorp shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Labcorp shares outstanding for the quarter ending March 31, 2024 were 0.085B, a 4.83% decline year-over-year.
  • Labcorp 2023 shares outstanding were 0.088B, a 4.37% decline from 2022.
  • Labcorp 2022 shares outstanding were 0.092B, a 6.05% decline from 2021.
  • Labcorp 2021 shares outstanding were 0.098B, a 0.51% decline from 2020.
Labcorp Annual Shares Outstanding
(Millions of Shares)
2023 88
2022 92
2021 98
2020 98
2019 99
2018 103
2017 104
2016 104
2015 101
2014 86
2013 92
2012 97
2011 102
2010 105
2009 109
Labcorp Quarterly Shares Outstanding
(Millions of Shares)
2024-03-31 85
2023-12-31 88
2023-09-30 87
2023-06-30 89
2023-03-31 89
2022-12-31 92
2022-09-30 91
2022-06-30 93
2022-03-31 94
2021-12-31 98
2021-09-30 97
2021-06-30 98
2021-03-31 99
2020-12-31 98
2020-09-30 98
2020-06-30 98
2020-03-31 97
2019-12-31 99
2019-09-30 98
2019-06-30 99
2019-03-31 100
2018-12-31 103
2018-09-30 103
2018-06-30 103
2018-03-31 103
2017-12-31 104
2017-09-30 104
2017-06-30 104
2017-03-31 104
2016-12-31 104
2016-09-30 105
2016-06-30 104
2016-03-31 104
2015-12-31 101
2015-09-30 103
2015-06-30 103
2015-03-31 94
2014-12-31 86
2014-09-30 87
2014-06-30 86
2014-03-31 87
2013-12-31 92
2013-09-30 91
2013-06-30 94
2013-03-31 95
2012-12-31 97
2012-09-30 97
2012-06-30 98
2012-03-31 99
2011-12-31 102
2011-09-30 102
2011-06-30 103
2011-03-31 103
2010-12-31 105
2010-09-30 104
2010-06-30 105
2010-03-31 107
2009-12-31 109
2009-09-30 109
2009-06-30 110
2009-03-31 109
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $16.691B $12.162B
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $71.394B 19.11
Becton Dickinson (BDX) United States $66.895B 19.43
West Pharmaceutical Services (WST) United States $26.385B 47.05
Cardinal Health (CAH) United States $25.104B 15.09
Align Technology (ALGN) United States $23.254B 44.92
Cooper (COO) United States $17.657B 26.72
Henry Schein (HSIC) United States $9.396B 16.25
DENTSPLY SIRONA (XRAY) United States $6.339B 16.70
Merit Medical Systems (MMSI) United States $4.284B 24.51
Patterson (PDCO) United States $2.309B 11.06
STAAR Surgical (STAA) United States $2.307B 72.25
CONMED (CNMD) United States $2.025B 18.37
Atrion (ATRI) United States $0.695B 35.81
Lifevantage (LFVN) United States $0.080B 12.89
Pro-Dex (PDEX) United States $0.066B 24.91
Biolase (BIOL) United States $0.005B 0.00